| Net Cash Provided by (Used in) Operating Activities |
$70,593 |
USD |
15% |
Q1 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$69,475 |
USD |
-16% |
Q1 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Investing Activities |
$0 |
USD |
|
Q1 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
650,000,000 |
shares |
0% |
Q3 2025 |
Q3 2026 |
| Common Stock, Shares, Issued |
53,957,572 |
shares |
0% |
Q3 2025 |
Q3 2026 |
| Common Stock, Par or Stated Value Per Share |
0.0001 |
USD/shares |
0% |
Q3 2025 |
Q3 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$1,914 |
USD |
-53% |
Q3 2025 |
Q3 2026 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$0 |
USD |
|
Q1 2025 |
Q1 2026 |
| Deferred Tax Assets, Valuation Allowance |
$14,574,000 |
USD |
2.1% |
Q4 2024 |
FY 2025 |
| Deferred Tax Assets, Gross |
$14,574,000 |
USD |
2.1% |
Q4 2024 |
FY 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$69,400,000 |
USD |
2.1% |
Q4 2024 |
FY 2025 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
Q3 2026 |
| Preferred Stock, Shares Authorized |
50,000,000 |
shares |
0% |
Q3 2025 |
Q3 2026 |
| Additional Paid in Capital |
$62,166,104 |
USD |
0% |
Q3 2025 |
Q3 2026 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2025 |
Q3 2026 |
| Deferred Tax Assets, Net of Valuation Allowance |
$0 |
USD |
|
Q4 2024 |
FY 2025 |
| Interest Expense |
$39,528 |
USD |
2.9% |
Q3 2025 |
Q3 2026 |
| Preferred Stock, Par or Stated Value Per Share |
0.001 |
USD/shares |
0% |
Q3 2025 |
Q3 2026 |